[#item_full_content] The company reports 30% net revenue growth in cannabis segment, 18% growth in Canada medical cannabis revenue and 17% growth in Canada adult-use cannabis revenue. It also strengthens end-to-end EU GMP supply chain to facilitate further international growth. Read More